Remedium Lifecare declared their Q3 FY24 results on 14 Feb, 2024. The topline increased by 939.33% & the profit increased by 2910.88% YoY.
As compared to the previous quarter, the revenue grew by 291.44% and the profit increased by 601.96%.
The Selling, general & administrative expenses declined by 18.77% q-o-q & decreased by 56.94% YoY.
The operating income was up by 561.25% q-o-q & increased by 4367.71% YoY.
The EPS is ₹34.12 for Q3 FY24 which increased by 4417.11% YoY.
Remedium Lifecare has delivered 16.61% return in the last 1 week, -34.64% return in last 6 months and 7.61% YTD return.
Currently, Remedium Lifecare has a market cap of ₹1087.73 Cr and 52wk high/low of ₹898.3 & ₹35.32 respectively.
Remedium Lifecare Financials
| Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
|---|
| Total Revenue | 1834.18 | 468.57 | +291.44% | 176.48 | +939.33% |
| Selling/ General/ Admin Expenses Total | 0.17 | 0.21 | -18.77% | 0.4 | -56.94% |
| Depreciation/ Amortization | 0.01 | 0.01 | -10.07% | 0.01 | +8.06% |
| Total Operating Expense | 1765.38 | 458.16 | +285.31% | 174.94 | +909.15% |
| Operating Income | 68.8 | 10.4 | +561.25% | 1.54 | +4367.71% |
| Net Income Before Taxes | 68.78 | 10.4 | +561.01% | 1.52 | +4419.75% |
| Net Income | 45.82 | 6.53 | +601.96% | 1.52 | +2910.88% |
| Diluted Normalized EPS | 34.12 | 3.24 | +953.88% | 0.76 | +4417.11% |
Stay updated on quarterly results with our
results calendar
